Generic Nucynta Officially Barred After Depomed Patent Win
A New Jersey federal judge on Tuesday entered a final judgment and injunction barring Actavis Inc., Roxane Laboratories Inc. and Alkem Laboratories Ltd. from releasing generic versions of Depomed Inc.'s opioid...To view the full article, register now.
Already a subscriber? Click here to view full article